150 related articles for article (PubMed ID: 30342189)
21. Identification of N-acetylcysteine conjugates of 1,2-dibromo-3-chloropropane: evidence for cytochrome P450 and glutathione mediated bioactivation pathways.
Weber GL; Steenwyk RC; Nelson SD; Pearson PG
Chem Res Toxicol; 1995 Jun; 8(4):560-73. PubMed ID: 7548736
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
[TBL] [Abstract][Full Text] [Related]
23. Degraded protein adducts of cis-2-butene-1,4-dial are urinary and hepatocyte metabolites of furan.
Lu D; Sullivan MM; Phillips MB; Peterson LA
Chem Res Toxicol; 2009 Jun; 22(6):997-1007. PubMed ID: 19441776
[TBL] [Abstract][Full Text] [Related]
24. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.
Pirmohamed M; Kitteringham NR; Guenthner TM; Breckenridge AM; Park BK
Biochem Pharmacol; 1992 Apr; 43(8):1675-82. PubMed ID: 1575766
[TBL] [Abstract][Full Text] [Related]
25. Carbamazepine is degraded by the bacterial strain Labrys portucalensis F11.
Bessa VS; Moreira IS; Murgolo S; Mascolo G; Castro PML
Sci Total Environ; 2019 Nov; 690():739-747. PubMed ID: 31301512
[TBL] [Abstract][Full Text] [Related]
26. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Powell G; Saunders M; Marson AG
Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
[TBL] [Abstract][Full Text] [Related]
27. Oxcarbazepine.
Tecoma ES
Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
[TBL] [Abstract][Full Text] [Related]
28. Degradation kinetics and metabolites of carbamazepine in soil.
Li J; Dodgen L; Ye Q; Gan J
Environ Sci Technol; 2013 Apr; 47(8):3678-84. PubMed ID: 23506704
[TBL] [Abstract][Full Text] [Related]
29. Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.
Simper GS; Hò GT; Celik AA; Huyton T; Kuhn J; Kunze-Schumacher H; Blasczyk R; Bade-Döding C
J Immunol Res; 2018; 2018():5086503. PubMed ID: 30302345
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
31. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
32. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
[TBL] [Abstract][Full Text] [Related]
33. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Friis ML; Christiansen J; Hvidberg EF
Eur J Clin Pharmacol; 1978 Nov; 14(1):47-51. PubMed ID: 729606
[TBL] [Abstract][Full Text] [Related]
34. Experiments and numerical simulation on the degradation processes of carbamazepine and triclosan in surface water: A case study for the Shahe Stream, South China.
Yuan X; Li S; Hu J; Yu M; Li Y; Wang Z
Sci Total Environ; 2019 Mar; 655():1125-1138. PubMed ID: 30577106
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine.
Oscarson M; Zanger UM; Rifki OF; Klein K; Eichelbaum M; Meyer UA
Clin Pharmacol Ther; 2006 Nov; 80(5):440-456. PubMed ID: 17112801
[TBL] [Abstract][Full Text] [Related]
36. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
37. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.
Sasaki E; Yokoi T
J Toxicol Sci; 2018; 43(2):75-87. PubMed ID: 29479037
[TBL] [Abstract][Full Text] [Related]
38. Insight into the generation of toxic products during chloramination of carbamazepine: Kinetics, transformation pathway and toxicity.
Han Y; Ma M; Oda Y; Rao K; Wang Z; Yang R; Liu Y
Sci Total Environ; 2019 Aug; 679():221-228. PubMed ID: 31082595
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry.
Shokry E; Villanelli F; Malvagia S; Rosati A; Forni G; Funghini S; Ombrone D; Della Bona M; Guerrini R; la Marca G
J Pharm Biomed Anal; 2015 May; 109():164-70. PubMed ID: 25770414
[TBL] [Abstract][Full Text] [Related]
40. Carbamazepine adverse drug reactions.
Fricke-Galindo I; LLerena A; Jung-Cook H; López-López M
Expert Rev Clin Pharmacol; 2018 Jul; 11(7):705-718. PubMed ID: 29898616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
